Covance was acquired by Labcorp in 2015 and officially rebranded as Labcorp Drug Development in 2021. In 2023, the clinical development portion was spun off as an independent company named Fortrea . Key Services:
The name can refer to two very different things: a global drug development company (now rebranded) or a blood pressure medication . 1. Covance (The Company) COVANCE
Are you interested in through the company, or Overview of Covance Clinical Research and Drug Discovery Covance was acquired by Labcorp in 2015 and
Reduces the risk of in patients with an enlarged heart. Protects kidney function in patients with Type 2 diabetes. Volunteers can find active clinical trials through the
Volunteers can find active clinical trials through the official Labcorp site or ClinicalTrials.gov . 2. Covance (The Medication)
It is an Angiotensin II Receptor Blocker (ARB) that relaxes blood vessels to lower pressure and ease heart strain.
Operating central laboratories for specimen testing and medical device verification.